-
Cocoa Extract for the Integumentary system
|
|
-
Coconut Oil for the Integumentary system
|
|
-
Feverfew for the Integumentary system
|
|
-
Ginkgo biloba for the Integumentary system
|
|
-
Guduchi for the Integumentary system
|
|
-
Inositol for the Integumentary system
|
|
-
Kutki for the Integumentary system
|
|
-
Milk Thistle for the Integumentary system
|
|
-
Minoxidil for the Integumentary system
|
In this 48-week study of 381 women with female pattern hair loss, 5% topical minoxidil was superior to placebo on each of the 3 primary efficacy end points: promoting hair growth as measured by change in nonvellus hair count and patient/investigator assessments of hair growth and scalp coverage.
|
Hair count results show a modest and sustained improvement in hair growth with daily use of a 1% pyrithione zinc shampoo over a 26-week treatment period.
|
In contrast, the 5% and 2% minoxidil treatment groups showed a statistically significant increase in mean percentage change in interval weight from baseline compared with placebo; results for number counts were usually less significant. Over 96 weeks, topical minoxidil induced and maintained an increase in interval weight over baseline of about 30%. After treatment was stopped, hair weight and number counts for the minoxidil groups returned to about the same levels as placebo in 24 weeks.
|
In men with AGA, 5% topical minoxidil was clearly superior to 2% topical minoxidil and placebo in increasing hair regrowth, and the magnitude of its effect was marked (45% more hair regrowth than 2% topical minoxidil at week 48). Men who used 5% topical minoxidil also had an earlier response to treatment than those who used 2% topical minoxidil. Psychosocial perceptions of hair loss in men with AGA were also improved. Topical minoxidil (5% and 2%) was well tolerated by the men in this trial without evidence of systemic effects.
|
In this comparative study of systemic finasteride and topical minoxidil, it was concluded that both drugs were effective and safe in the treatment of mild to severe AGA, although oral finasteride treatment was more effective (p < 0.05). Adverse events were not considered important either, and these side effects disappeared as soon as the treatment was stopped.
|
Once-daily 5% MTF is noninferior and as effective for stimulating hair growth as twice-daily 2% MTS in women with androgenetic alopecia and is associated with several aesthetic and practical advantages.
|
The difference between the groups was significant (P = 0.020). The incidence of adverse events was 8.7% (13/150) in the 5% group and 5.3% (8/150) in the 1% group, with no significant difference between the groups (chi(2)-test: P = 0.258). Our findings confirmed the superiority of 5% topical minoxidil to 1% topical minoxidil in treating Japanese men with androgenetic alopecia.
|
We believe that 5% MTF is a safe and effective treatment for men with AGA.
|
|
-
Orthosiphon stamineus for the Integumentary system
|
|
-
Polypodium leucotomos for the Integumentary system
|
|
-
Resveratrol for the Integumentary system
|
|
-
Vitamin A for the Integumentary system
|
Fourteen of the 15 patients who received tretinoin to the face had improvement in photoaging, whereas none of the vehicle-treated patients' faces improved, a statistically significant difference in response between the two groups. Statistically significant histologic changes were seen in forearm skin treated with tretinoin, but not with vehicle cream. Side effects were limited to irritation of tretinoin-exposed skin.
|
Significant reductions were found in fine wrinkling, mottled hyperpigmentation, roughness, and laxity after 0.05% tretinoin therapy when compared with controls. In addition, histologic changes of increased epidermal thickness, decreased melanin content, and stratum corneum compaction provide independent evidence supporting clinical improvement. Side effects of erythema, peeling, and stinging were usually mild and well tolerated.
|
Topical retinol improves fine wrinkles associated with natural aging. Significant induction of glycosaminoglycan, which is known to retain substantial water, and increased collagen production are most likely responsible for wrinkle effacement. With greater skin matrix synthesis, retinol-treated aged skin is more likely to withstand skin injury and ulcer formation along with improved appearance.
|
Tretinoin 0.1% and 0.025% produce similar clinical and histologic changes in patients with photoaging, despite significantly greater incidence of irritation with the higher concentration. The separation between clinical improvement and irritation suggests that mechanisms other than irritation dominate tretinoin-induced repair of photoaging in humans.
|
|
-
Vitamin B3 for the Integumentary system
|
|
-
Zinc for the Integumentary system
|
|
-
Alpha-Lipoic Acid for the Integumentary system
|
|
-
Bladderwrack for the Integumentary system
|
|
-
Boswellia serrata for the Integumentary system
|
|
-
Chia seeds for the Integumentary system
|
|
-
Chromium for the Integumentary system
|
|
-
Coenzyme Q10 for the Integumentary system
|
|
-
Drumstick Tree for the Integumentary system
|
|
-
Fish Oil for the Integumentary system
|
|
-
Grape Seed Extract for the Integumentary system
|
|
-
Green Tea Extract for the Integumentary system
|
|
-
Hemp Protein for the Integumentary system
|
|
-
Pycnogenol for the Integumentary system
|
|
-
Raspberry Ketone for the Integumentary system
|
|
-
Red Clover Extract for the Integumentary system
|
|
-
Rose Hip for the Integumentary system
|
|
-
Rosemary Extract for the Integumentary system
|
|
-
Saw Palmetto for the Integumentary system
|
|
-
Vitamin E for the Integumentary system
|
|
-
Vitamin K for the Integumentary system
|
|
-
White Mulberry for the Integumentary system
|
|
-
N-Acetylcysteine for the Integumentary system
|
|